M
Elixir Phenomen · Sweden
CERTIFICATE OF ANALYSIS
ISO/IEC 17025 · GMP-aligned · For research use only
Document №
COA-EP-58071-Z
Issued
2026-06-12
Product name
Semax
Category
Nootropic & Neuro
CAS №
80714-61-0
Molecular weight
813.9 g/mol
Quantity / Vial
10 mg
Appearance
White lyophilized powder
Batch №
EP-58071-Z
Lot
L4071
Date of analysis
2026-06-01
Expiry (lyophilized, −20 °C)
2029-06-12
Analytical Results
| Test | Method | Specification | Result | Pass |
|---|---|---|---|---|
| Purity | RP-HPLC | ≥ 99% | 99.61 % | ✓ |
| Identity | ESI-MS | Matches theoretical mass | 99.80 % match | ✓ |
| Water content | Karl Fischer | ≤ 6.0 % | 2.34 % | ✓ |
| Acetate content | Ion chromatography | ≤ 12.0 % | 7.78 % | ✓ |
| Endotoxin | LAL kinetic | ≤ 1.0 EU/mg | 0.373 EU/mg | ✓ |
| Bioburden | Plate count | ≤ 100 CFU/g | < 10 CFU/g | ✓ |
| Appearance | Visual | White powder | Conforms | ✓ |
| Solubility | Bacteriostatic water | Clear, colourless | Conforms | ✓ |
Research scope
Category
Nootropic & Neuro
Reference note
ACTH(4-10) analog.
Batch EP-58071-Z har testats enligt intern SOP-PEP-002 och uppfyller samtliga release-specifikationer ovan. Lagras lyofiliserad vid −20 °C, skyddad från ljus. Endast för laboratorieforskning. Ej för humant eller veterinärt bruk.
Analyzed & released by
Assam
Assam
Senior Analytical Chemist · QA Release
Testing laboratory
Malmö Intelligent Lab Analysis
Andrés Bello 2425
Providencia, Santiago
Chile
Providencia, Santiago
Chile
Lab ID: MILA-CL-2018-PEP
CERTIFIED
M·I·L·A
2026-06-01